OVIDREL
Google image searchProduct monograph
Active ingredient
choriogonadotropin alfa, 250 MCG/0.5 ML
DIN: 02262088
Dosage form(s): SOLUTION
Route(s) of administration: SUBCUTANEOUS
Schedule: Prescription / Schedule D
Company: EMD SERONO, A DIVISION OF EMD INC., CANADA
Date: 20-DEC-2004
ATC:
- G03 — SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM (ATC, ATC/DDD, )
- G03G — GONADOTROPINS AND OTHER OVULATION STIMULANTS (ATC, ATC/DDD)
- G03GA — Gonadotropins (ATC, ATC/DDD)
- G03GA08 — CHORIOGONADOTROPIN ALFA (ATC/DDD)
Reference brand drug: Ovidrel
Pharmaceutical standard: MFR
